Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim N01 vs rhTPO for Refractory CTIT
NCT06440824Phase 3Not yet recruiting
- Sponsor
- Shandong University
- Start
- Jun 2024
- Primary completion
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of romiplostim in Thrombocytopenia, sponsored by Shandong University. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
romiplostim
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT06440824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06440824.